Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Amblyopia treatment of adults with dichoptic training using the virtual reality oculus rift head mounted display: preliminary results

P. Žiak, A. Holm, J. Halička, P. Mojžiš, DP. Piñero,

. 2017 ; 17 (1) : 105. [pub] 20170628

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18016514

BACKGROUND: The gold standard treatments in amblyopia are penalizing therapies, such as patching or blurring vision with atropine that are aimed at forcing the use of the amblyopic eye. However, in the last years, new therapies are being developed and validated, such as dichoptic visual training, aimed at stimulating the amblyopic eye and eliminating the interocular supression. PURPOSE: To evaluate the effect of dichoptic visual training using a virtual reality head mounted display in a sample of anisometropic amblyopic adults and to evaluate the potential usefulness of this option of treatment. METHODS: A total of 17 subjects (10 men, 7 women) with a mean age of 31.2 years (range, 17-69 year) and anisometropic amblyopia were enrolled. Best corrected visual acuity (BCVA) and stereoacuity (Stereo Randot graded circle test) changes were evaluated after 8 sessions (40 min per session) of dichoptic training with the computer game Diplopia Game (Vivid Vision) run in the Oculus Rift OC DK2 virtual reality head mounted display (Oculus VR). RESULTS: Mean BCVA in amblyopic eye improved significantly from a logMAR value of 0.58 ± 0.35 before training to a post-training value of 0.43 ± 0.38 (p < 0.01). Forty-seven percent of the participants achieved BCVA of 20/40 or better after the training as compared to 30% before the training. Mean stereoacuity changed from a value of 263.3 ± 135.1 before dichoptic training to a value of 176.7 ± 152.4 s of arc after training (p < 0.01). A total of 8 patients (47.1%) before dichoptic treatment had unmeasurable stereoacuity while this only occurred in 2 patients (11.8%) after training. CONCLUSIONS: Dichoptic training using a virtual reality head mounted display seems to be an effective option of treatment in adults with anisometropic amblyopia. Future clinical trials are needed to confirm this preliminary evidence. TRIAL REGISTRATION: Trial ID: ISRCTN62086471 . Date registered: 13/06/2017. Retrospectively registered.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016514
003      
CZ-PrNML
005      
20180517093811.0
007      
ta
008      
180515s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12886-017-0501-8 $2 doi
035    __
$a (PubMed)28659140
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Žiak, Peter $u Eye clinic, Jessenius faculty of Medicine in Martin, Commenius University in Bratislava, Bratislava, Slovakia. 1ziakpeter@gmail.com. UVEA Mediklinik, Martin, Slovakia. 1ziakpeter@gmail.com.
245    10
$a Amblyopia treatment of adults with dichoptic training using the virtual reality oculus rift head mounted display: preliminary results / $c P. Žiak, A. Holm, J. Halička, P. Mojžiš, DP. Piñero,
520    9_
$a BACKGROUND: The gold standard treatments in amblyopia are penalizing therapies, such as patching or blurring vision with atropine that are aimed at forcing the use of the amblyopic eye. However, in the last years, new therapies are being developed and validated, such as dichoptic visual training, aimed at stimulating the amblyopic eye and eliminating the interocular supression. PURPOSE: To evaluate the effect of dichoptic visual training using a virtual reality head mounted display in a sample of anisometropic amblyopic adults and to evaluate the potential usefulness of this option of treatment. METHODS: A total of 17 subjects (10 men, 7 women) with a mean age of 31.2 years (range, 17-69 year) and anisometropic amblyopia were enrolled. Best corrected visual acuity (BCVA) and stereoacuity (Stereo Randot graded circle test) changes were evaluated after 8 sessions (40 min per session) of dichoptic training with the computer game Diplopia Game (Vivid Vision) run in the Oculus Rift OC DK2 virtual reality head mounted display (Oculus VR). RESULTS: Mean BCVA in amblyopic eye improved significantly from a logMAR value of 0.58 ± 0.35 before training to a post-training value of 0.43 ± 0.38 (p < 0.01). Forty-seven percent of the participants achieved BCVA of 20/40 or better after the training as compared to 30% before the training. Mean stereoacuity changed from a value of 263.3 ± 135.1 before dichoptic training to a value of 176.7 ± 152.4 s of arc after training (p < 0.01). A total of 8 patients (47.1%) before dichoptic treatment had unmeasurable stereoacuity while this only occurred in 2 patients (11.8%) after training. CONCLUSIONS: Dichoptic training using a virtual reality head mounted display seems to be an effective option of treatment in adults with anisometropic amblyopia. Future clinical trials are needed to confirm this preliminary evidence. TRIAL REGISTRATION: Trial ID: ISRCTN62086471 . Date registered: 13/06/2017. Retrospectively registered.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a amblyopie $x patofyziologie $x terapie $7 D000550
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    12
$a zobrazování trojrozměrné $7 D021621
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a deformace percepce $x fyziologie $7 D010469
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a senzorická deprivace $7 D012683
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
650    _2
$a terapie pomocí virtuální reality $x metody $7 D063367
650    _2
$a vidění binokulární $x fyziologie $7 D015348
650    12
$a zraková ostrost $7 D014792
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Holm, Anders $u Eye clinic, Jessenius faculty of Medicine in Martin, Commenius University in Bratislava, Bratislava, Slovakia. UVEA Mediklinik, Martin, Slovakia.
700    1_
$a Halička, Juraj $u Eye clinic, Jessenius faculty of Medicine in Martin, Commenius University in Bratislava, Bratislava, Slovakia. UVEA Mediklinik, Martin, Slovakia.
700    1_
$a Mojžiš, Peter $u Premium Clinic, Teplice, Czech Republic.
700    1_
$a Piñero, David P $u Department of Optics, Pharmacology and Anatomy, University of Alicante, Alicante, Spain.
773    0_
$w MED00008199 $t BMC ophthalmology $x 1471-2415 $g Roč. 17, č. 1 (2017), s. 105
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28659140 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180517093947 $b ABA008
999    __
$a ok $b bmc $g 1300138 $s 1013354
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 17 $c 1 $d 105 $e 20170628 $i 1471-2415 $m BMC ophthalmology $n BMC Ophthalmol $x MED00008199
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Možnosti archivace